Upcoming Webinars
Building the House of Rapid Sterility – A Successful Platform Approach to introducing Rapid Methods
Presented by Sophie Drinkwater, Senior Scientist in Microbiology at AstraZeneca, Jon Kallay, Senior Scientific Portfolio Specialist, Charles River Microbial Solutions
18th April 2024
Building an Innovative Integrated Continuous Downstream Manufacturing Platform for the Production of Biologics
Presented by Irina Ramos, Director, Bioprocess Technology and Engineering at AstraZeneca
18th June 2024
Application of Portable Spectrometers in Pharmaceutical Forensics
Presented by Brittany Handzo, Scientist, Forensics and Innovative Technologies at Bristol-Myers Squibb and Ravi Kalyanaraman, PhD, Director of the Forensics and Innovative Technologies at Bristol-Myers Squibb
27th June 2024
De-bottlenecking Challenges in Large Scale Viral Vector Manufacturing for Gene Therapy Applications
Presented by Presented by Prateek Gupta, PhD Senior Vice President, Process Development & MSAT at Stelis Biopharma
11th July 2024
On Demand Webinars
Validation of Test Result Equivalence for Alternative BET assays, Including Recombinant Methods
Presented by Karen Zink McCullough, Owner, Principal Consultant at MMI Associates, John Duguid, Executive Director, Research & Development at Vericel Corporation, Steven Walfish, Principal Consultant at Statistical Outsourcing Services, Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza and Alan Hoffmeister, Senior Global Technology and Market Development Manager at Charles River
27th March 2024
The Importance of Viral Clearance and Characterization in Gene Therapy Products
Presented by Ya-Chen Chang, Principal Scientist, downstream process development team at Regenxbio, Akunna Iheanacho, Ph.D. Chief Scientific Officer at Texcell – North America, Inc, Katelyn Pritchard, Viral Clearance Study Director at Texcell - North America, Inc and Maja Leskovec, Head of Process Development Viruses at Sartorius BIA Separations
19th March 2024
Leachable Risk Assessment Approaches: A Comparison of USP <665>, Biophorum, and Other Methods For Assessing Leachable Risk In Biopharmaceutical Manufacturing Systems
Presented by Presented by Jason Creasey, Managing Director at Maven E&L Ltd Managing Director at Maven E&L Ltd and Koen Smets, PhD, Senior Expert Extractables and Leachables at Nelson Labs NV
18th March 2024
Current State of PAT Applications for a Reliable and Effective PCM Equipment Operation
Presented by Richard Steiner, Senior Manager Business Strategy at Pharmatech Associates, A USP Company and Uwe Kirschner, Managing Director at Sentronic GmBH
11th March 2024